WHO WE ARE

The Development of Novel Glycobiomarker/IVD. 

RCMG Inc. is a technology-based company and we KNOW HOW to detect “differences” specific to disease conditions suitable for the diversity of personalized medicine.

WHO WE ARE

RCMG Inc. for Human Health

RCMG Inc.

About Us

RCMG’s proprietary technology platform is able to continually create novel biomarkers/in vitro diagnostics (IVDs) to detect specific disease conditions suitable for the diversity of personalized medicine.

Chain

Glycomedicine

In the Glycoscience, new technologies based on engineering in addition to biochemistry and molecular biology promote new findings in medicine.

RCMG Inc.

Hepatitis B Virus

Hepatitis B virus (HBV), one of the most human infected viruses, has been a global health problem. A recombinant monoclonal antibody against HBsAg glycan isomer (HBsAgGi) was cloned and available from RCMG Inc.

News Topics

RCMG Inc.


2-1-6 Sengen, Plaza suite 209, Tsukuba, Ibaraki 305-0047
TEL:+81-29-828-8010

Contact Us



© Copyright 2024 RCMG Inc.